Navigation Links
Dr. Floyd Bloom Joins aTyr Pharma's Scientific Advisory Board
Date:10/14/2009

SAN DIEGO, Oct. 14 /PRNewswire/ -- aTyr Pharma announced today that Dr. Floyd Bloom Professor Emeritus, Molecular and Integrative Neuroscience Department at The Scripps Research Institute, has joined their scientific advisory board. A widely acknowledged leader in the field of neurosciences, Dr. Bloom has been recognized with many honors, including elected membership to the National Academy of Sciences, the Institute of Medicine, the American Philosophical Society and the Royal Swedish Academy of Science. With over 400 scientific publications to his name, Dr. Bloom brings rigorous and extensive scientific experience in understanding the biology and impact of drugs on human diseases. This scientific expertise and perspective will be extremely valuable to aTyr Pharma's novel class of biotherapeutics being discovered and developed to treat a wide variety of diseases, including neurological disorders. Based on an entirely new class of naturally occurring proteins, the aTyr Pharma drug pipeline consists of proteins hidden in the aminoacyl tRNA synthetases. Key enzymes in protein synthesis, aminoacyl tRNA synthetases have recently been shown to have resected forms arising from splice variations or proteolysis, known as resectins. These resectins have distinct functions not related to protein synthesis that can be exploited for development as biotherapeutics.

According to Jeff Watson, Ph. D. and CEO of aTyr Pharma, "Developing a new class of biologics with applications in a number of therapeutic areas such as inflammation, cardiovascular, hematology, neurology and metabolism requires deep knowledge in particular disease areas. Dr. Bloom is the consummate scientist in the field of neurobiology, and has shown ability to translate that knowledge into human therapies by his founding and role as CEO at Neurome. We are thrilled to be able to apply his knowledge and expertise to our understanding of resectin biology."

Professor Paul Schi
'/>"/>

SOURCE aTyr Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Imagenetix, Inc. Announces Interview With Bloomberg Radio
2. BioMarin Corrects Information Included in Bloomberg Article
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
5. Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research
6. Barby K. Siegel Joins Zeno Group as Chief Executive Officer
7. LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory
8. Sanford Rose Associates Joins the International Executive Search Federation
9. Christopher Brennan Joins PharmaNet Development Group as General Counsel
10. Richard Gephardt Joins Leading Innovators in Washington State to Call for Greater Focus on Policies to Boost Economy and Maintain U.S. Competitiveness in Medical Science and Innovation
11. John J. Young, Jr. Joins SRI Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ES(Nasdaq: IESC ),aleadingnationalproviderofelectr...rcial,industrialandresidentialmarkets,announcedtod...tractfromManhattanTorconJVtoinstalltheelectricalsy...cilityattheU.S.ArmyMedicalResearchInstituteofInfec.... ,, ThenewUSAMRIIDreplacementfacilitywilladdap...
(Date:11/24/2009)...omoreprestigiousuniversitieshavejoinedBioCareerCen...forlifescienceprofessionals. ,, Northwesternand...ng28othermajorlifesciencetrainingInstitutions. ,...post-graduatesinthelifesciences.Whiletherearehundr...Centeristheonlyonethatserveslifesciencepost-gradua...
(Date:11/24/2009)...Sigma-AldrichCorporation(Nasdaq: SIAL )willbeprese...at1:45PMGMTinLondon,7:45AMUS/CST.Interestedparties...ableat http://inve s tor.sig m a a ldrich.c...e. ,, AboutSigma-Aldrich: Sigma-Aldrichisale...alandbiochemicalproductsandkitsareusedinscientific...
(Date:11/24/2009)...armaceuticalsInc.announced,theUSPatent&Tradema...nano-particleoraldeliveryorNODtechnology. , N...epeptidesor,proteinsintobio-adhesivenano-particles...sinjections.NODtechnologyisaplatformtechnology,tha...n,interferon,growthhormone,exenatide,heparinandmo...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
...hted at the 14th Congress of the European Hematolo... Data in Breast Cancer to Be Presented at the Amer... , BETHESDA, Md., May 20 Micromet, Inc. (Nasdaq:...novel, proprietary antibodies for the treatment of...ay announced an oral(1) and a poster presentation(...
...ay 19 InfraReDx, Inc. announced today the first u...ses both light and sound to image coronary plaques.... Martin van der Ent performed the procedures on M...raphy at the Thoraxcenter. , , The combination ...RS imaging in a single study of the artery. IVUS ...
... , , ATLANTA, May 19 Meeting at the world,s lar...Kansas Bioscience Authority has approved more than...million initiative to help researchers and busines...s made at the Bio International Convention will cr...als and plant biology, expand cancer drug developm...
Other Biology Technology:Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO 2Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO 3Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO 4Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO 5First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter 2First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter 3As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 2As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 3As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 4
(Date:11/23/2009)...y of New Hampshire microbiologist Louis Tisa has r...derstanding of the actinorhizal plants, widespread...or and contaminated soils. , The United States ...rofessor of molecular, cellular and biomedical sci...hip between the bacteria Frankia and Casuarina, an...
(Date:11/23/2009)...California biomedical engineer and cardiologist Tz...lp clinicians distinguish cardiac emergencies requ...geable with drugs and lifestyle change. , Angiog...rteries feeding the heart, offer an inside view of...sels, often revealing deposits of a dangerous fatt...
(Date:11/23/2009)... toads have existed for 360 million years and surv...fungus is threatening to make many of them extinct... Microbiology Today . , The fungus, Batrachoc...iated with waves of amphibian extinctions in Centr...,s. Bd infects over 350 amphibian species by penet...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 1Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 2Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 3Martin Hensen head of e strategies UCB Germany 3A Making e marketing more than just an add on 9458 1The Caryl Ehrlich Program Discusses Food Addiction on HealthyPlace com 53495 1The Caryl Ehrlich Program Discusses Food Addiction on HealthyPlace com 53495 2
...ventive measure to patients in intensive care unit... has emerged from a study involving nearly sixthou...hers at University Medical Center (UMC) Utrecht ha...New England Journal of Medicine . , During the s... two kinds of antibiotic treatments with the stand...
...e seeds forces laboratory leukemia cells to commit...niversity of Kentucky. They found that within 24 h...being exposed to the extract. , The investigators..., issue of Clinical Cancer Research , a journal o...so teased apart the cell signaling pathway associa...
...tamin C or E or a combination of the supplements h...ake the supplements, according to data from a rand...issue of the Journal of the National Cancer Insti...hat people whose diets are high in fruits and vege...sk of cancer. Results from randomized trials that ...
Other Biology News:Fewer deaths with preventive antibiotic use 2Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds 2Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial 2
Mouse Anti-C1-inhibitor (C1-INH) Monoclonal Antibody, Unconjugated, Clone 8F3 from AntibodyShop A/S
...Certify products ATP-Free using Mo Bio luciferase ...ive ATP-Free certification service that will allow... level of accuracy and enable you to deliver them ... detection limit is 3.5 x 10-12 /l, which will all...
Mouse Anti-Human Choriongonadotropin (hCG) Monoclonal Antibody, Unconjugated, Clone 5F10 from AntibodyShop A/S
...Small Molecule Localization in Early Drug Developm...al drug compound localization data in early drug d...erys imaging mass spectrometry service maps unlab...s so you can localize drugs and metabolites prior ...
Biology Products: